{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:08:39Z","timestamp":1789960119772,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T00:00:00Z","timestamp":1248393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/cgt.2009.50","type":"journal-article","created":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T10:17:27Z","timestamp":1248430647000},"page":"73-79","source":"Crossref","is-referenced-by-count":38,"title":["Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model"],"prefix":"10.1038","volume":"17","author":[{"given":"J-H","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-S","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-K","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-Y","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-H","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Trown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"Kirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T-H","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,24]]},"reference":[{"key":"BFcgt200950_CR1","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539\u20133543.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt200950_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1158\/1078-0432.CCR-05-1059","volume":"12","author":"N Ramesh","year":"2006","unstructured":"Ramesh N, Ge Y, Ennist DL, Zhu M, Mina M, Ganesh S et al. CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor\u2014armed oncolytic adenovirus for the treatment of bladder cancer. Clin Cancer Res 2006; 12: 305\u2013313.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200950_CR3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.cgt.7701070","volume":"14","author":"SI Kohno","year":"2007","unstructured":"Kohno SI, Luo C, Nawa A, Fujimoto Y, Watanabe D, Goshima F et al. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus. Cancer Gene Ther 2007; 14: 918\u2013926.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt200950_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ymthe.2006.05.008","volume":"14","author":"JH Kim","year":"2006","unstructured":"Kim JH, Oh JY, Park BH, Lee DE, Kim JS, Park HE et al. Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF. Mol Ther 2006; 14: 361\u2013370.","journal-title":"Mol Ther"},{"key":"BFcgt200950_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.surg.2006.10.010","volume":"141","author":"S Malhotra","year":"2007","unstructured":"Malhotra S, Kim T, Zager J, Bennett J, Ebright M, D'Angelica M et al. Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas. Surgery 2007; 141: 520\u2013529.","journal-title":"Surgery"},{"key":"BFcgt200950_CR6","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1016\/S1470-2045(08)70107-4","volume":"9","author":"BH Park","year":"2008","unstructured":"Park BH, Hwang TH, Liu TC, Sze DY, Kim JS, Kwon HC et al. Phase I clinical proof-of-concept trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with refractory primary or metastatic liver cancers. Lancet Oncol 2008; 9: 5330\u20135342.","journal-title":"Lancet Oncol"},{"key":"BFcgt200950_CR7","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/mt.2008.143","volume":"16","author":"TC Liu","year":"2008","unstructured":"Liu TC, Hwang TH, Park BH, Bell J, Kirn DH . The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma. Mol Ther 2008; 16: 1637\u20131642.","journal-title":"Mol Ther"},{"key":"BFcgt200950_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/sj.cgt.7700066","volume":"6","author":"MJ Mastrangelo","year":"1999","unstructured":"Mastrangelo MJ, Maguire Jr HC, Eisenlohr LC, Laughlin CE, Monken CE, McCue PA et al. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Ther 1999; 6: 409\u2013422.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt200950_CR9","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1172\/JCI32727","volume":"117","author":"SH Thorne","year":"2007","unstructured":"Thorne SH, Hwang TH, O'Gorman WE, Bartlett DL, Sei S, Kanji F et al. Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963. J Clin Invest 2007; 117: 3350\u20133358.","journal-title":"J Clin Invest"},{"key":"BFcgt200950_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1091\/mbc.6.5.497","volume":"6","author":"I Nishijima","year":"1995","unstructured":"Nishijima I, Nakahata T, Hirabayashi Y, Inoue T, Kurata H, Miyajima A et al. A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF. Mol Biol Cell 1995; 6: 497\u2013508.","journal-title":"Mol Biol Cell"},{"key":"BFcgt200950_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1172\/JCI117767","volume":"95","author":"HW Murray","year":"1995","unstructured":"Murray HW . Effect of granulocyte\u2013macrophage colony-stimulating factor in experimental visceral leishmaniasis. J Clin Invest 1995; 95: 1183\u20131192.","journal-title":"J Clin Invest"},{"key":"BFcgt200950_CR12","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1016\/S0021-9258(18)92772-9","volume":"266","author":"AB Shanafelt","year":"1991","unstructured":"Shanafelt AB, Johnson KE, Kastelein RA . Identification of critical amino acid residues in human and mouse granulocyte\u2013macrophage colony-stimulating factor and their involvement in species specificity. J Biol Chem 1991; 266: 13804\u201313810.","journal-title":"J Biol Chem"},{"key":"BFcgt200950_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1073\/pnas.89.2.628","volume":"89","author":"SN Isaacs","year":"1992","unstructured":"Isaacs SN, Kotwal GJ, Moss B . Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci USA 1992; 89: 628\u2013632.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt200950_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.vetimm.2004.08.022","volume":"103","author":"V Cody","year":"2005","unstructured":"Cody V, Shen H, Shlyankevich M, Tigelaar RE, Brandsma JL, Hanlon DJ . Generation of dendritic cells from rabbit bone marrow mononuclear cell cultures supplemented with hGM-CSF and hIL-4. Vet Immunol Immunopathol 2005; 103: 163\u2013172.","journal-title":"Vet Immunol Immunopathol"},{"key":"BFcgt200950_CR15","first-page":"362","volume":"19","author":"GD Demetri","year":"1992","unstructured":"Demetri GD, Antman KH . Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigations. Semin Oncol 1992; 19: 362\u2013385.","journal-title":"Semin Oncol"},{"key":"BFcgt200950_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1172\/JCI113139","volume":"80","author":"CA Sieff","year":"1987","unstructured":"Sieff CA, Niemeyer CM, Nathan DG, Ekern SC, Bieber FR, Yang YC et al. Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3. J Clin Invest 1987; 80: 818\u2013823.","journal-title":"J Clin Invest"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cgt200950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt200950","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt200950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:13:54Z","timestamp":1684415634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt200950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,24]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFcgt200950"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2009.50","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,24]]}}}